Symbols / VANI Stock $1.34 -3.60% Vivani Medical, Inc.

Healthcare • Biotechnology • United States • NCM
VANI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Adam Mendelsohn Ph.D.
Exch · Country NCM · United States
Market Cap 113.43M
Enterprise Value 120.28M
Income -26.61M
Sales —
FCF (ttm) -15.89M
Book/sh 0.21
Cash/sh 0.19
Employees 42
Insider 10d —
IPO Nov 19, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -3.83
PEG —
P/S —
P/B 6.50
P/C —
EV/EBITDA -4.43
EV/Sales —
Quick Ratio 2.56
Current Ratio 2.71
Debt/Eq 119.87
LT Debt/Eq —
EPS (ttm) -0.43
EPS next Y -0.35
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-13
Earnings (prior) 2026-03-26
ROA -42.55%
ROE -159.62%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 84.65M
Shs Float 37.27M
Insider Own 34.34%
Instit Own 6.42%
Short Float 0.86%
Short Ratio 2.44
Short Interest 529.86K
52W High 1.92
vs 52W High -30.21%
52W Low 0.92
vs 52W Low 45.18%
Beta 3.37
Impl. Vol. 1.71%
Rel Volume 0.41
Avg Volume 300.75K
Volume 123.36K
Target (mean) $4.83
Tgt Median $4.00
Tgt Low $3.50
Tgt High $7.00
# Analysts 3
Recom Strong_buy
Prev Close $1.39
Price $1.34
Change -3.60%
About

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.83
Mean price target
2. Current target
$1.34
Latest analyst target
3. DCF / Fair value
$-3.38
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.34
Low
$3.50
High
$7.00
Mean
$4.83

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-31 main HC Wainwright & Co. Buy → Buy $4
2025-09-02 reit HC Wainwright & Co. Buy → Buy $4
2025-05-19 reit HC Wainwright & Co. Buy → Buy $4
2025-04-16 reit HC Wainwright & Co. Buy → Buy $4
2025-04-04 reit HC Wainwright & Co. Buy → Buy $4
2025-03-26 reit HC Wainwright & Co. Buy → Buy $4
2025-03-13 reit HC Wainwright & Co. Buy → Buy $4
2024-11-07 init HC Wainwright & Co. — → Buy $3
2022-12-05 init ThinkEquity — → Buy $7
News
RSS: Latest VANI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,587,301 $1.26 $1,999,999
2026-03-13 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,575,231 $1.03 $1,683,335
2026-02-13 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,866,492 $1.03 $1,983,333
2026-01-27 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,351,351 $1.48 $1,999,999
2026-01-15 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,737,765 $1.12 $1,983,334
2025-12-29 MENDELSOHN AARON Director — 20,000 $1.23 $24,600
2025-12-15 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,737,765 $1.12 $1,983,334
2025-11-14 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,737,764 $1.26 $2,425,297
2025-10-27 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 3,703,703 $1.62 $5,999,999
2025-10-15 WILLIAMS GREGG Director and Beneficial Owner of more than 10% of a Class of Security — 1,737,764 $1.12 $1,983,333
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
27.56
+11.67%
24.68
-8.49%
26.96
+26.95%
21.24
Research And Development
18.13
+15.12%
15.74
-7.21%
16.97
+19.75%
14.17
Selling General And Administration
9.43
+5.58%
8.93
-10.65%
10.00
+41.36%
7.07
General And Administrative Expense
9.43
+5.58%
8.93
-10.65%
10.00
+41.36%
7.07
Other Gand A
9.43
+5.58%
8.93
-10.65%
10.00
+41.36%
7.07
Total Expenses
27.56
+11.67%
24.68
-8.49%
26.96
+26.95%
21.24
Operating Income
-27.56
-11.67%
-24.68
+8.49%
-26.96
-26.95%
-21.24
Total Operating Income As Reported
-27.56
-11.67%
-24.68
+8.49%
-26.96
-26.95%
-21.24
EBITDA
-27.13
-11.76%
-24.28
+8.76%
-26.61
-27.56%
-20.86
Normalized EBITDA
-27.13
-11.76%
-24.28
+8.76%
-26.61
-27.56%
-20.86
Reconciled Depreciation
0.42
+6.00%
0.40
+12.04%
0.36
-6.30%
0.38
EBIT
-27.56
-11.67%
-24.68
+8.49%
-26.96
-26.95%
-21.24
Total Unusual Items
—
—
—
6.88
Total Unusual Items Excluding Goodwill
—
—
—
6.88
Special Income Charges
—
—
—
6.88
Other Special Charges
—
—
—
—
Restructuring And Mergern Acquisition
—
—
—
-6.88
Net Income
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Pretax Income
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Other Income Expense
0.95
-20.49%
1.19
-9.29%
1.31
-82.14%
7.35
Other Non Operating Income Expenses
0.95
-20.49%
1.19
-9.29%
1.31
-82.14%
7.35
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Net Income From Continuing Operation Net Minority Interest
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Net Income From Continuing And Discontinued Operation
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Net Income Continuous Operations
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Normalized Income
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Net Income Common Stockholders
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Diluted EPS
-0.43
+0.00%
-0.43
+14.00%
-0.50
-38.89%
-0.36
Basic EPS
-0.43
+0.00%
-0.43
+14.00%
-0.50
-38.89%
-0.36
Basic Average Shares
62.39
+13.47%
54.98
+8.12%
50.85
+32.98%
38.24
Diluted Average Shares
62.39
+13.47%
54.98
+8.12%
50.85
+32.98%
38.24
Diluted NI Availto Com Stockholders
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
39.39
-5.22%
41.56
-9.25%
45.80
-10.43%
51.13
Current Assets
17.90
-12.44%
20.44
-11.36%
23.06
-51.48%
47.53
Cash Cash Equivalents And Short Term Investments
16.23
-11.55%
18.35
-11.15%
20.65
-54.18%
45.08
Cash And Cash Equivalents
16.23
-11.55%
18.35
-11.15%
20.65
-54.18%
45.08
Receivables
0.65
+158.50%
0.25
0.00
—
Taxes Receivable
0.65
+158.50%
0.25
0.00
—
Prepaid Assets
—
—
—
—
Other Current Assets
1.01
-44.91%
1.84
-23.71%
2.41
-1.79%
2.45
Total Non Current Assets
21.50
+1.78%
21.12
-7.11%
22.73
+531.18%
3.60
Net PPE
20.11
+2.34%
19.65
-7.94%
21.34
+988.48%
1.96
Gross PPE
23.16
+3.91%
22.29
-6.29%
23.79
+444.08%
4.37
Accumulated Depreciation
-3.05
-15.64%
-2.64
-8.15%
-2.44
-1.29%
-2.41
Properties
—
—
0.00
0.00
Machinery Furniture Equipment
0.41
+3.27%
0.40
+9.97%
0.36
+491.80%
0.06
Construction In Progress
1.36
0.00
-100.00%
0.30
0.00
Other Properties
21.39
-2.30%
21.89
-5.33%
23.13
+437.96%
4.30
Leases
—
—
0.00
-100.00%
0.01
Non Current Prepaid Assets
0.05
-63.36%
0.13
+151.92%
0.05
-81.09%
0.28
Other Non Current Assets
1.34
+0.00%
1.34
-3.74%
1.39
+1.76%
1.37
Total Liabilities Net Minority Interest
23.66
-1.20%
23.95
-4.33%
25.04
+266.99%
6.82
Current Liabilities
6.60
+10.29%
5.99
+4.60%
5.72
-16.11%
6.82
Payables And Accrued Expenses
4.44
+3.45%
4.29
+8.90%
3.94
-24.30%
5.21
Payables
1.03
+26.32%
0.82
+50.74%
0.54
-53.95%
1.18
Accounts Payable
1.03
+26.32%
0.82
+50.74%
0.54
-53.95%
1.18
Current Accrued Expenses
3.41
-1.93%
3.48
+2.23%
3.40
-15.65%
4.03
Pensionand Other Post Retirement Benefit Plans Current
0.36
+6.41%
0.34
-13.38%
0.40
-39.73%
0.66
Current Debt And Capital Lease Obligation
1.79
+33.09%
1.35
-2.53%
1.38
+44.82%
0.95
Current Capital Lease Obligation
1.79
+33.09%
1.35
-2.53%
1.38
+44.82%
0.95
Total Non Current Liabilities Net Minority Interest
17.06
-5.03%
17.96
-6.98%
19.31
0.00
Long Term Debt And Capital Lease Obligation
17.06
-5.03%
17.96
-6.98%
19.31
0.00
Long Term Capital Lease Obligation
17.06
-5.03%
17.96
-6.98%
19.31
0.00
Stockholders Equity
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Common Stock Equity
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Capital Stock
0.01
+33.33%
0.01
+20.00%
0.01
+0.00%
0.01
Common Stock
0.01
+33.33%
0.01
+20.00%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
76.43
+29.03%
59.23
+16.08%
51.03
+0.58%
50.74
Ordinary Shares Number
76.43
+29.03%
59.23
+16.08%
51.03
+0.58%
50.74
Additional Paid In Capital
164.22
+17.74%
139.48
+17.16%
119.05
+1.71%
117.05
Retained Earnings
-148.53
-21.82%
-121.92
-23.86%
-98.44
-35.24%
-72.79
Gains Losses Not Affecting Retained Earnings
0.03
-37.50%
0.05
-65.71%
0.14
+300.00%
0.04
Other Equity Adjustments
0.03
-37.50%
0.05
-65.71%
0.14
+300.00%
0.04
Total Equity Gross Minority Interest
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Total Capitalization
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Working Capital
11.30
-21.86%
14.46
-16.63%
17.34
-57.40%
40.71
Invested Capital
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Total Debt
18.86
-2.37%
19.31
-6.68%
20.70
+2067.12%
0.95
Capital Lease Obligations
18.86
-2.37%
19.31
-6.68%
20.70
+2067.12%
0.95
Net Tangible Assets
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Tangible Book Value
15.73
-10.68%
17.61
-15.18%
20.76
-53.14%
44.31
Line Of Credit
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-24.32
-17.00%
-20.79
+12.29%
-23.70
-26.15%
-18.79
Cash Flow From Continuing Operating Activities
-24.32
-17.00%
-20.79
+12.29%
-23.70
-26.15%
-18.79
Net Income From Continuing Operations
-26.61
-13.30%
-23.49
+8.44%
-25.65
-84.69%
-13.89
Depreciation Amortization Depletion
0.42
+6.00%
0.40
+12.04%
0.36
-6.30%
0.38
Depreciation And Amortization
0.42
+6.00%
0.40
+12.04%
0.36
-6.30%
0.38
Other Non Cash Items
0.27
-2.54%
0.28
-69.47%
0.90
+113.08%
-6.91
Stock Based Compensation
1.48
-7.83%
1.61
-13.63%
1.86
+43.83%
1.30
Asset Impairment Charge
0.00
-100.00%
0.06
-50.41%
0.12
—
Operating Gains Losses
-0.12
—
0.12
—
Net Foreign Currency Exchange Gain Loss
-0.12
0.00
—
—
Gain Loss On Sale Of PPE
—
—
0.12
0.00
Change In Working Capital
0.23
-35.31%
0.35
+127.38%
-1.29
-482.54%
0.34
Change In Receivables
-0.40
-58.50%
-0.25
0.00
—
Change In Prepaid Assets
0.91
+84.93%
0.49
+85.98%
0.26
+155.46%
-0.48
Change In Payables And Accrued Expense
-0.28
-339.66%
0.12
+107.45%
-1.56
-291.28%
0.81
Change In Accrued Expense
-0.06
+57.58%
-0.13
+86.18%
-0.95
-134.66%
2.75
Change In Payable
-0.22
-189.52%
0.25
+141.20%
-0.60
+68.99%
-1.94
Change In Account Payable
-0.22
-189.52%
0.25
+141.20%
-0.60
+68.99%
-1.94
Change In Other Working Capital
—
—
—
0.20
Change In Other Current Liabilities
—
—
—
—
Investing Cash Flow
-1.17
-110.97%
-0.56
+37.32%
-0.89
-162.43%
-0.34
Cash Flow From Continuing Investing Activities
-1.17
-110.97%
-0.56
+37.32%
-0.89
-162.43%
-0.34
Net PPE Purchase And Sale
-1.17
-110.97%
-0.56
+37.32%
-0.89
-162.43%
-0.34
Purchase Of PPE
-1.17
-110.97%
-0.56
+37.32%
-0.89
-162.43%
-0.34
Capital Expenditure
-1.17
-110.97%
-0.56
+37.32%
-0.89
-162.43%
-0.34
Financing Cash Flow
23.27
+22.15%
19.05
+14226.32%
0.13
-99.79%
63.39
Cash Flow From Continuing Financing Activities
23.27
+22.15%
19.05
+14226.32%
0.13
-99.79%
63.39
Net Issuance Payments Of Debt
0.01
-95.36%
0.24
0.00
—
Issuance Of Debt
0.35
-16.67%
0.43
0.00
—
Repayment Of Debt
-0.34
-82.01%
-0.19
—
—
Long Term Debt Payments
-0.34
-82.01%
-0.19
—
—
Net Long Term Debt Issuance
-0.34
-82.01%
-0.19
—
—
Short Term Debt Issuance
0.35
-16.67%
0.43
0.00
—
Net Short Term Debt Issuance
0.35
-16.67%
0.43
0.00
—
Net Common Stock Issuance
23.26
+23.63%
18.82
0.00
-100.00%
0.02
Common Stock Payments
-0.03
—
—
—
Repurchase Of Capital Stock
-0.03
—
—
—
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.13
—
Net Other Financing Charges
—
-0.19
—
63.37
Changes In Cash
-2.22
+3.02%
-2.29
+90.64%
-24.45
-155.24%
44.27
Effect Of Exchange Rate Changes
0.10
+807.14%
-0.01
-566.67%
0.00
+400.00%
-0.00
Beginning Cash Position
19.69
-10.47%
21.99
-52.65%
46.44
+2032.32%
2.18
End Cash Position
17.57
-10.77%
19.69
-10.47%
21.99
-52.65%
46.44
Free Cash Flow
-25.49
-19.45%
-21.34
+13.19%
-24.59
-28.55%
-19.12
Income Tax Paid Supplemental Data
0.00
-100.00%
0.00
+100.00%
0.00
0.00
Common Stock Issuance
23.29
+23.78%
18.82
0.00
-100.00%
0.02
Issuance Of Capital Stock
23.29
+23.78%
18.82
0.00
-100.00%
0.02
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category